Bio Break: How much does it cost to develop a medical device?

Resources

Bio Break: How much does it cost to develop a medical device?

YouTube video thumbnail

What are the real costs of developing a medical device? In this episode of Bio Break, Nick and Joris dive into one of the most frequently asked questions they hear from clients: How much does it cost to develop a medical device?

When companies approach a product development firm like StarFish Medical, they usually bring a set of expectations around cost, timeline, and quality — what Nick calls the “holy trinity” of client expectations. But aligning these expectations with reality can be a challenge, especially for startups or first-time medical device entrepreneurs.

Nick and Joris explore what drives the cost of medical device development, from simple devices like tongue depressors to complex systems like MRI machines. They highlight that costs vary widely depending on the device type, how mature the technology is, and whether there are existing components to leverage.

For example, when a client already has a validated lab-developed test (LDT) and wants to turn it into a product like an ELISA kit or a lateral flow assay, the development cost can be relatively modest — potentially a few hundred thousand dollars. In contrast, developing entirely new technology — where the scientific principles haven’t been proven and significant technical uncertainties remain — requires larger teams and longer timelines, driving costs into the millions.

Joris also points out that leveraging off-the-shelf components and reusing existing technologies can help reduce costs, but when you’re inventing something truly novel, the cost of technical innovation quickly adds up.

Finally, they remind viewers that clinical trials, regulatory approvals, and manufacturing scale-up will introduce additional costs beyond early prototyping and design.

Rightness Trap Medtech concept showing a crossroads decision with opposing directional signs

Jason McGee explores how the Rightness Trap Medtech dynamic can quietly erode enterprise value in medical device companies.

Gram positive vs negative bacteria explained with diagram and comparison

Understanding gram positive vs negative bacteria is essential when studying sterility, microbiology, and antibiotic effectiveness. While many people think the difference is only about staining, the reality is much deeper.

Alcohol disrupting bacterial cell membrane explaining why 70 percent sanitizer kills bacteria more effectively

Nick and Nigel explore the science behind hand sanitizer formulations. They discuss how alcohol interacts with bacterial cells, why water improves its effectiveness, and what the additional ingredients in sanitizer actually do.

Scott Phillips of StarFish Medical and Peter van der Velden of Lumira Ventures speaking at a MedTech transactions webinar

Scott Phillips, CEO of StarFish Medical, sits down with Peter van der Velden, Managing General Partner at Lumira Ventures, to explore the strategic thinking behind major MedTech transactions and investments.